BE2015C011I2 - - Google Patents

Download PDF

Info

Publication number
BE2015C011I2
BE2015C011I2 BE2015C011C BE2015C011C BE2015C011I2 BE 2015C011 I2 BE2015C011 I2 BE 2015C011I2 BE 2015C011 C BE2015C011 C BE 2015C011C BE 2015C011 C BE2015C011 C BE 2015C011C BE 2015C011 I2 BE2015C011 I2 BE 2015C011I2
Authority
BE
Belgium
Application number
BE2015C011C
Other languages
French (fr)
Original Assignee
Idexx Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idexx Lab Inc filed Critical Idexx Lab Inc
Publication of BE2015C011I2 publication Critical patent/BE2015C011I2/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE2015C011C 2004-06-24 2015-01-27 BE2015C011I2 (enrdf_load_html_response)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/874,532 US7854943B2 (en) 2004-06-24 2004-06-24 Phospholipid gel compositions for drug delivery and methods of treating conditions using same

Publications (1)

Publication Number Publication Date
BE2015C011I2 true BE2015C011I2 (enrdf_load_html_response) 2024-10-08

Family

ID=35506068

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2015C011C BE2015C011I2 (enrdf_load_html_response) 2004-06-24 2015-01-27

Country Status (4)

Country Link
US (1) US7854943B2 (enrdf_load_html_response)
CN (1) CN101014323B (enrdf_load_html_response)
BE (1) BE2015C011I2 (enrdf_load_html_response)
HU (1) HUS1500004I1 (enrdf_load_html_response)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7858115B2 (en) * 2004-06-24 2010-12-28 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
US8017159B2 (en) * 2005-11-16 2011-09-13 Idexx Laboratories, Inc. Phospholipid gel compositions for delivery of aptamers and methods of treating conditions using same
US9115358B2 (en) 2006-08-11 2015-08-25 President And Fellows Of Harvard College Moenomycin biosynthesis-related compositions and methods of use thereof
EP2205074A4 (en) * 2007-10-04 2013-07-31 Harvard College MOENOMYCIN ANALOGUE, SYNTHESIS PROCESS AND USE
WO2010033726A2 (en) 2008-09-17 2010-03-25 The Brigham And Women's Hospital, Inc. Drug delivery composition comprising a self-assembled gelator
EP3412279B1 (en) 2010-09-24 2021-02-17 The Brigham and Women's Hospital, Inc. Nanostructured gels capable of controlled release of encapsulated agents
WO2013151697A1 (en) 2012-04-06 2013-10-10 President And Fellows Of Harvard College Methods and compounds for identifying glycosyltransferase inhibitors
WO2013152277A2 (en) 2012-04-06 2013-10-10 President And Fellows Of Harvard College Moenomycin analogs, methods of synthesis, and uses thereof
WO2013152279A1 (en) 2012-04-06 2013-10-10 President And Fellows Of Harvard College Chemoenzymatic methods for synthesizing moenomycin analogs
GB201511058D0 (en) * 2015-06-23 2015-08-05 Lamellar Biomedical Ltd Compositions and methods for using lamellar bodies for therapeutic purposes
JP7169880B2 (ja) 2016-05-06 2022-11-11 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド 軟骨へのカプセル化薬剤の制御送達のための二成分型自己集合ゲル
WO2018144991A1 (en) 2017-02-03 2018-08-09 The Brigham And Women's Hospital, Inc. Self-assembled gels formed with anti-retroviral drugs, prodrugs thereof, and pharmaceutical uses thereof
WO2018208822A1 (en) * 2017-05-08 2018-11-15 Alivio Therapeutics, Inc. Formulation of nanostructured gels for increased agent loading and adhesion
CN113825495A (zh) 2018-10-11 2021-12-21 阿利维奥治疗学股份有限公司 用于智能释放的不可注射水凝胶调配物
EP4117870A4 (en) * 2020-03-09 2024-07-03 Idexx Laboratories, Inc. Method for removing interfering components of a liquid sample prior to dispensing same on a chemical reagent test slide
WO2021221066A1 (ja) * 2020-04-28 2021-11-04 株式会社レオロジー機能食品研究所 免疫機能亢進用組成物

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909466A (en) 1956-05-29 1959-10-20 Pfizer & Co C Stable solutions of oxytetracycline salts
US4025620A (en) 1975-10-22 1977-05-24 Leo Pharmaceutical Products Ltd., A/S Treatment of canine otitis and composition therefor
IL52448A (en) 1976-07-06 1981-09-13 Bayer Ag Antimycotic and sporicidal pharmaceutical compositions comprising imidazol-1-yl-(4-phenoxy-phenyl)-(pyridin-2-yl)phenyl methane
IE53610B1 (en) 1981-12-14 1988-12-21 Merck & Co Inc Waterless thixotropic composition
JPS6087215A (ja) 1983-10-19 1985-05-16 Mitsui Toatsu Chem Inc 外用薬用基材
FR2570602B1 (fr) 1984-09-21 1986-11-28 Cird Vehicule pharmaceutique pour substances actives se presentant sous forme d'un gel anhydre
US4678516A (en) 1984-10-09 1987-07-07 The Dow Chemical Company Sustained release dosage form based on highly plasticized cellulose ether gels
US4837008A (en) 1985-04-09 1989-06-06 Peroxydent Group Periodontal composition and method
US4843096A (en) 1985-06-26 1989-06-27 Stiefel Laboratories, Inc. Treatment of acne
US4847267A (en) 1986-03-17 1989-07-11 Charles Of The Ritz Group Ltd. Skin treatment composition and method
US5091171B2 (en) 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
US4814173A (en) 1987-09-08 1989-03-21 Warner-Lambert Company Silicone elastomer transdermal matrix system
US5446070A (en) 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5110809A (en) 1988-03-21 1992-05-05 Bristol-Myers Squibb Company Antifungal gel formulations
AU639844B2 (en) 1990-11-09 1993-08-05 Otsuka Pharmaceutical Co., Ltd. Procaterol-containing plaster
HU223343B1 (hu) 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
US6005001A (en) 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
US5656355A (en) * 1992-03-12 1997-08-12 Kimberly-Clark Corporation Multilayer elastic metallized material
ZA934893B (en) 1992-07-20 1995-01-09 Colgate Palmolive Co Gelled organic liquids
US5631004A (en) 1993-09-30 1997-05-20 Alcon Laboratories, Inc. Use of sustained release antibiotic compositions in ophthalmic surgical procedures
US5516808A (en) 1994-10-27 1996-05-14 Sawaya; Assad S. Topical cellulose pharmaceutical formulation
US5849761A (en) * 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US5736152A (en) * 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
WO1998006407A1 (en) 1996-07-30 1998-02-19 Ashmont Holdings Limited Anthelmintic formulations
US6130200A (en) * 1996-12-20 2000-10-10 Alza Corporation Gel composition and methods
US6630168B1 (en) 1997-02-20 2003-10-07 Biomedicines, Inc. Gel delivery vehicles for anticellular proliferative agents
US6018033A (en) 1997-05-13 2000-01-25 Purdue Research Foundation Hydrophilic, hydrophobic, and thermoreversible saccharide gels and forms, and methods for producing same
WO1999030690A1 (en) * 1997-12-15 1999-06-24 Axia Therapeutics, Inc. Oral delivery formulation
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
US6436455B2 (en) 1998-06-15 2002-08-20 General Mills, Inc. Multi-colored aerated confectionery products
US6146664A (en) 1998-07-10 2000-11-14 Shaklee Corporation Stable topical ascorbic acid compositions
GB2340751B (en) 1998-08-12 2003-11-05 Edko Trading Representation Pharmaceutical compositions
US6238683B1 (en) 1998-12-04 2001-05-29 Johnson & Johnson Consumer Companies, Inc. Anhydrous topical skin preparations
US6395300B1 (en) 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
US7919119B2 (en) 1999-05-27 2011-04-05 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
US6214339B1 (en) 2000-01-12 2001-04-10 Michael A. Pellico Di-enzymatic treatment of outer ear infection in dogs and cats
US6565873B1 (en) 2000-10-25 2003-05-20 Salvona Llc Biodegradable bioadhesive controlled release system of nano-particles for oral care products
US6787568B1 (en) 2000-11-27 2004-09-07 Phoenix Scientific, Inc. Antibiotic/analgesic formulation and a method of making this formulation
BRPI0213425B8 (pt) 2001-10-19 2021-05-25 Idexx Lab Inc composições injetáveis para a liberação controlada de composto farmacologicamente ativo, usos do referido composto e método para suas preparações
AU2003301516A1 (en) 2002-10-24 2004-05-13 Goldstein, Jay A Antifungal formulations
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
US7220431B2 (en) 2002-11-27 2007-05-22 Regents Of The University Of Minnesota Methods and compositions for applying pharmacologic agents to the ear
US20040197408A1 (en) 2002-12-30 2004-10-07 Angiotech International Ag Amino acids in micelle preparation
US20040220264A1 (en) 2003-03-17 2004-11-04 Yu Ruey J Bioavailability and improved delivery of acidic pharmaceutical drugs
US20040214753A1 (en) 2003-03-20 2004-10-28 Britten Nancy Jean Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
US20050009931A1 (en) 2003-03-20 2005-01-13 Britten Nancy Jean Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
WO2004082588A2 (en) 2003-03-20 2004-09-30 Pharmacia Corporation Dispersible formulation of an anti-inflammatory agent
WO2004093870A1 (en) 2003-03-20 2004-11-04 Pharmacia Corporation Treatment and prevention of otic disorders
US8003616B2 (en) 2004-04-23 2011-08-23 Albert Rory J Composition for the treatment of ear infections and method
US7618651B2 (en) 2004-06-24 2009-11-17 Idexx Laboratories Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same

Also Published As

Publication number Publication date
HUS1500004I1 (hu) 2017-09-28
US20050287198A1 (en) 2005-12-29
CN101014323B (zh) 2012-09-05
CN101014323A (zh) 2007-08-08
US7854943B2 (en) 2010-12-21

Similar Documents

Publication Publication Date Title
BE2024C508I2 (enrdf_load_html_response)
BE2022C549I2 (enrdf_load_html_response)
BE2023C542I2 (enrdf_load_html_response)
BE2021C001I2 (enrdf_load_html_response)
BE2020C513I2 (enrdf_load_html_response)
BE2020C517I2 (enrdf_load_html_response)
BE2019C540I2 (enrdf_load_html_response)
BE2019C523I2 (enrdf_load_html_response)
BE2019C506I2 (enrdf_load_html_response)
BE2019C548I2 (enrdf_load_html_response)
BE2018C045I2 (enrdf_load_html_response)
BE2017C063I2 (enrdf_load_html_response)
BE2020C525I2 (enrdf_load_html_response)
BE2017C027I2 (enrdf_load_html_response)
BE2017C023I2 (enrdf_load_html_response)
BE2017C002I2 (enrdf_load_html_response)
BE2016C067I2 (enrdf_load_html_response)
BE2016C014I2 (enrdf_load_html_response)
BE2015C041I2 (enrdf_load_html_response)
BE2015C038I2 (enrdf_load_html_response)
BE2015C014I2 (enrdf_load_html_response)
BE2015C015I2 (enrdf_load_html_response)
BE2015C066I2 (enrdf_load_html_response)
BE2014C071I2 (enrdf_load_html_response)
BE2014C064I2 (enrdf_load_html_response)